1. Home
  2. COCP vs SIF Comparison

COCP vs SIF Comparison

Compare COCP & SIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • SIF
  • Stock Information
  • Founded
  • COCP N/A
  • SIF 1913
  • Country
  • COCP United States
  • SIF United States
  • Employees
  • COCP N/A
  • SIF N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • SIF Office Equipment/Supplies/Services
  • Sector
  • COCP Health Care
  • SIF Industrials
  • Exchange
  • COCP Nasdaq
  • SIF Nasdaq
  • Market Cap
  • COCP 20.1M
  • SIF 22.6M
  • IPO Year
  • COCP N/A
  • SIF N/A
  • Fundamental
  • Price
  • COCP $1.98
  • SIF $3.64
  • Analyst Decision
  • COCP Strong Buy
  • SIF
  • Analyst Count
  • COCP 1
  • SIF 0
  • Target Price
  • COCP $7.00
  • SIF N/A
  • AVG Volume (30 Days)
  • COCP 93.7K
  • SIF 11.7K
  • Earning Date
  • COCP 11-13-2024
  • SIF 02-12-2025
  • Dividend Yield
  • COCP N/A
  • SIF N/A
  • EPS Growth
  • COCP N/A
  • SIF N/A
  • EPS
  • COCP N/A
  • SIF N/A
  • Revenue
  • COCP N/A
  • SIF $79,633,000.00
  • Revenue This Year
  • COCP N/A
  • SIF N/A
  • Revenue Next Year
  • COCP N/A
  • SIF N/A
  • P/E Ratio
  • COCP N/A
  • SIF N/A
  • Revenue Growth
  • COCP N/A
  • SIF 20.53
  • 52 Week Low
  • COCP $1.33
  • SIF $2.87
  • 52 Week High
  • COCP $3.26
  • SIF $5.96
  • Technical
  • Relative Strength Index (RSI)
  • COCP 44.30
  • SIF 49.18
  • Support Level
  • COCP $2.21
  • SIF $3.52
  • Resistance Level
  • COCP $2.60
  • SIF $3.80
  • Average True Range (ATR)
  • COCP 0.33
  • SIF 0.15
  • MACD
  • COCP -0.07
  • SIF 0.01
  • Stochastic Oscillator
  • COCP 4.81
  • SIF 54.29

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About SIF SIFCO Industries Inc.

SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.

Share on Social Networks: